BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
68.63
-0.29 (-0.42%)
At close: Jun 23, 2026, 4:00 PM EDT
69.00
+0.37 (0.54%)
After-hours: Jun 23, 2026, 7:09 PM EDT
BridgeBio Pharma Stock Forecast
Stock Price Forecast
According to 24 analysts polled by S&P Global, BridgeBio Pharma stock has a consensus rating of "Strong Buy" and an average price target of $102.28. The average 1-year stock price forecast is 49.03% higher than the current stock price, while the lowest is $76 (+10.74%) and the highest is $157 (+128.76%).
Price Target: $102.28 (+49.03%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BridgeBio Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 15 | 15 | 16 | 16 | 15 | 16 |
| Buy | 5 | 5 | 5 | 6 | 6 | 6 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 22 | 23 | 23 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Maintains $125 → $98 | Buy | Maintains | $125 → $98 | +42.79% | Jun 17, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $106 → $96 | Buy | Maintains | $106 → $96 | +39.88% | Jun 15, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $101 | Buy | Maintains | $101 | +47.17% | Jun 11, 2026 |
| Barclays | Barclays | Buy Maintains $157 | Buy | Maintains | $157 | +128.76% | Jun 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $104 | Buy | Initiates | $104 | +51.54% | Jun 3, 2026 |
Financial Forecast
Revenue This Year
968.76M
from 502.08M
Increased by 92.95%
Revenue Next Year
1.60B
from 968.76M
Increased by 65.28%
EPS This Year
-2.18
from -3.78
EPS Next Year
0.53
from -2.18
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.1B | ||
| Avg | 968.8M | ||
| Low | 844.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 120.2% | ||
| Avg | 93.0% | ||
| Low | 68.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.49 | ||
| Avg | -2.18 | ||
| Low | -2.62 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |